Cargando…

MultiContrast Delayed Enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study

BACKGROUND: Myocardial infarction (MI) documented by late gadolinium enhancement (LGE) has clinical and prognostic importance, but its detection is sometimes compromised by poor contrast between blood and MI. MultiContrast Delayed Enhancement (MCODE) is a technique that helps discriminate subendocar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandettini, W Patricia, Kellman, Peter, Mancini, Christine, Booker, Oscar Julian, Vasu, Sujethra, Leung, Steve W, Wilson, Joel R, Shanbhag, Sujata M, Chen, Marcus Y, Arai, Andrew E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552709/ https://www.ncbi.nlm.nih.gov/pubmed/23199362 http://dx.doi.org/10.1186/1532-429X-14-83

Ejemplares similares

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Optimal timing of rest perfusion with regadenoson stress testing - normal volunteer study of quantitative MRI perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Mechanisms for overestimating acute myocardial infarct size with gadolinium-enhanced cardiovascular magnetic resonance imaging in humans: a quantitative and kinetic study(†)
por: Hammer-Hansen, Sophia, et al.
Publicado: (2016)

Impaired coronary vasodilation with Regadenoson in patients with angiographically normal coronaries when compared to normal volunteers - Insights from Quantitative MRI Perfusion
por: Vasu, Sujethra, et al.
Publicado: (2011)

Regadenoson is a better myocardial vasodilator than dipyridamole in normal volunteers, but the data is less compelling in patients
por: Vasu, Sujethra, et al.
Publicado: (2011)

A Rare Case of Hypertrophic Cardiomyopathy with Subendocardial Late Gadolinium Enhancement in an Apical Aneurysm with Thrombus
por: Morita, Yusuke, et al.
Publicado: (2014)

Concordance and diagnostic accuracy of vasodilator stress cardiac MRI and 320-detector row coronary CTA
por: Chen, Marcus Y., et al.
Publicado: (2013)

In the absence of obstructive coronary artery disease, patients with class II and III obesity have decreased myocardial perfusion reserve
por: Bandettini, W Patricia, et al.
Publicado: (2014)

Understanding why edema in salvaged myocardium is difficult to detect by late gadolinium enhancement
por: Ugander, Martin, et al.
Publicado: (2012)

Dark-blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of subendocardial scar: a review of current techniques
por: Holtackers, Robert J., et al.
Publicado: (2021)

High prevalence of atypical delayed enhancement in alkaptonuria
por: Chen, Marcus Y, et al.
Publicado: (2014)

Prevalence and prognosis of non-ischemic patterns of late gadolinium enhancement in older adults by cardiovascular MR in the ICELAND-MI study
por: Shanbhag, Sujata M, et al.
Publicado: (2016)

Detecting a subendocardial infarction in a child with coronary anomaly by three-dimensional late gadolinium enhancement MRI using compressed sensing
por: Suekuni, Hiroshi, et al.
Publicado: (2020)

Dispersion of hyperenhancement in late gadolinium enhancement cardiovascular magnetic resonance measured with Moran's I is associated with a decrement in LVEF 6 months after cardiotoxic chemotherapy
por: Jordan, Jennifer H, et al.
Publicado: (2013)

Clinical impact of cardiovascular magnetic resonance in evaluation for possible arrhythmogenic right ventricular dysplasia/cardiomyopathy
por: Choi, Andrew D, et al.
Publicado: (2015)

Dark blood Late Gadolinium Enhancement improves conspicuity of ablation lesions
por: Kellman, Peter, et al.
Publicado: (2016)

Characterization of cardiac masses with T1 mapping
por: Saba, Shahryar G, et al.
Publicado: (2015)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Heterogeneity of resting and hyperemic myocardial blood flow in healthy volunteers: a quantitative CMR perfusion pixel-map study
por: Greve, Anders M, et al.
Publicado: (2014)

Extracellular volume MRI increases the detection of myocardial abnormalities beyond late gadolinium enhancement - initial findings
por: Lundin, Magnus, et al.
Publicado: (2012)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Subendocardial Infarction in Severe Bicuspid Aortic Stenosis without Coronary Stenosis Confirmed by Contrast-enhanced Computed Tomography and Autopsy
por: Akiyama, Takumi, et al.
Publicado: (2022)

Comparison of gadolinium dose and acquisition time for late gadolinium enhancement at 3.0 T
por: Doltra, Adelina, et al.
Publicado: (2014)

Non-contrast-enhanced T(1) Mapping of Dilated Cardiomyopathy: Comparison between Native T(1) Values and Late Gadolinium Enhancement
por: Yanagisawa, Fumi, et al.
Publicado: (2018)

Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience
por: Kellman, Peter, et al.
Publicado: (2012)

Multicontrast 3D automated segmentation of cardiovascular images
por: Bramlet, Matthew, et al.
Publicado: (2016)

A multicontrast MR atlas of the Wistar rat brain
por: Allan Johnson, G., et al.
Publicado: (2021)

Late gadolinium enhancement in pulmonary hypertension predicts clinical events
por: Soma, Siva Kumar, et al.
Publicado: (2012)

Synthetic phase sensitive inversion recovery late gadolinium enhancement from post-contrast T1-mapping shows excellent agreement with conventional PSIR-LGE for diagnosing myocardial scar
por: Abdula, Goran, et al.
Publicado: (2014)

Subendocardial stress in pre‐eclampsia
por: Tran, Tomio, et al.
Publicado: (2020)

Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
por: Fontana, Marianna, et al.
Publicado: (2015)

Comparison of arterial input function measured from dual-bolus and dual-sequence dynamic contrast-enhanced cardiac magnetic resonance imaging
por: Hsu, Li-Yueh, et al.
Publicado: (2011)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Emerging Concepts for Myocardial Late Gadolinium Enhancement MRI
por: Doltra, Adelina, et al.
Publicado: (2013)

Late Gadolinium Enhancement after COVID-19 Vaccination
por: Wilson, Hunter, et al.
Publicado: (2021)

Role of Late Gadolinium Enhancement in the Assessment of Myocardial Viability
por: Shah, Dr. Viraj, et al.
Publicado: (2022)

Late gadolinium enhancement characteristics in giant cell myocarditis
por: Yang, Shujuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qapfakqpojncth1dgb2s7t52r6